Key highlights
- Johnson & Johnson announced a $1 billion investment in a cell therapy facility.
- The facility is located in Montgomery County, Pennsylvania.
- It aims to enhance manufacturing for cancer, immune-mediated, and neurological treatments.
Investment Announcement
Johnson & Johnson has announced a significant investment exceeding $1 billion in a new cell therapy manufacturing facility. This development is set to take place in Montgomery County, Pennsylvania.
Facility Purpose
The facility aims to expand the company's U.S. manufacturing capacity. It will focus on advancing treatments for cancer, immune-mediated, and neurological diseases.
